Rubicon Organics Reports Q2 2025 Financial and Operating Results

Executive Summary

• Rubicon Organics reported Q2 2025 net revenue of $15.0 million (up 24% year-over-year) and YTD net revenue of $27.4 million (up 30% year-over-year), achieving record gross profit and profit from operations.
• The company generated Adjusted EBITDA of $1.4 million in Q2 2025 and $2.1 million for the first half of 2025, marking the fifth consecutive quarter of positive Adjusted EBITDA.
• Strategic milestones include the completion of the Hope Facility acquisition (adding 4,500 kg of annual capacity, a >40% increase) and a private placement raising $4.5 million in gross proceeds.

Key Details

• Q2 2025 Financial Performance:
  • Net Revenue: $15.0 million (vs. $12.1 million in Q2 2024).
  • YTD Net Revenue: $27.4 million (vs. $21.0 million in H1 2024).
  • Adjusted EBITDA: $1.4 million for Q2 2025; $2.1 million for YTD.
  • Profit from Operations: $1.0 million for Q2 2025 (record high); $0.9 million for YTD.
  • Net Profit: $0.8 million for Q2 2025; $0.5 million for YTD.
  • Cash Flow from Operations: $0.8 million for Q2 2025; negative $0.2 million for YTD.
• YTD Financial Performance:
  • Gross Profit: $10.1 million (vs. $6.4 million in H1 2024).
  • Operating Expenses: $9.2 million (vs. $8.0 million in H1 2024).
  • Net Profit per Share (Basic): $0.01 for both Q2 and YTD.
• Balance Sheet Highlights (as of June 30, 2025):
  • Cash and Cash Equivalents: $7.3 million.
  • Total Assets: $60.6 million.
  • Total Shareholders' Equity: $42.8 million.
  • Working Capital: $21.2 million.
• Operational & Strategic Updates:
  • Hope Facility Acquisition: Closed on June 5, 2025. Adds 4,500 kg of annual production capacity, bringing total capacity to 15,500 kg. Licensing approval expected by year-end.
  • Start-up Costs: Anticipated $1–2 million in start-up operating costs for the Hope Facility in 2025; no revenue contribution expected until H1 2026.
  • Financing: Completed a private placement for aggregate gross proceeds of $4.5 million.
  • Product Launch: Launched 1964 Supply Co.™ All-in-One full spectrum extract resin vapes in July 2025.
  • Market Share (Jan-Jun 2025): 5.1% in premium flower/pre-rolls, 14.6% in resin vapes, 26.3% in premium edibles, and #1 topical SKU.
  • Awards: Won Standard Producer of the Year at Grow Up awards (May 2025).
  • Management: Glen Ibbott named Interim Chief Financial Officer.
• 2025 Outlook:
  • Forecasting growth in net revenue and Adjusted EBITDA (excluding Hope Costs).
  • Plans to acquire up to 2,000 kg of incremental biomass and utilize co-manufacturers.
  • International test shipments commenced in Q1 2025; aiming to meet small amounts of international demand while prioritizing Canadian customers.

Notable Quotes

• Margaret Brodie, CEO: “Our strong results reflect our relentless focus on quality across every aspect of our business. We’re now seeing the established success of our 510-thread FSE resin vapes, which have been in market for a full year, alongside momentum from our premium genetics—underscoring the strength of our genetic strategy. Looking ahead, I’m excited about the potential of our newly launched all-in-one FSE resin vapes, upcoming genetic releases, and the commissioning of our Hope Facility to support continued, sustainable growth.”
• Glen Ibbott, CFO: “We delivered a record-breaking quarter, achieving our highest-ever net revenue of $15.0 million, record gross profit, and a record profit from operations of $1.0 million. We also generated Adjusted EBITDA of $1.4 million and positive operating cash flow of $0.8 million. Our strong and consistent performance in the first half of the year reflects the strength of our operating model and our commitment to financial discipline. While we expect some one-time costs in the back half of the year as we invest in bringing the Hope Facility online, this is a strategic move to support long-term, sustainable value creation.”